Crispr Therapeutics shares owned by CMC Financial Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by CMC Financial Group
from 13F filings
Historical chart of CMC Financial Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by CMC Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by CMC Financial Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $451k | 6.6k | 68.16 |